Which has the lower trailing P/E, ALNY or IQV?

IQV has the lower trailing P/E: ALNY trades at 44.95 and IQV at 33.22. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, ALNY or IQV?

Over the past five years, ALNY grew revenue faster — ALNY at a 47.53% CAGR versus IQV at 5.61%.

Is ALNY or IQV more profitable?

ALNY runs the higher net margin — ALNY at 16.82% versus IQV at 8.10%.

How have ALNY and IQV total returns compared?

Over the past 10 years, ALNY delivered 14.42% and IQV delivered 13.27% annualized total return. Past performance doesn't predict future results.

Alnylam Pharmaceuticals, Inc. (ALNY) vs IQVIA Holdings Inc. (IQV)

A side-by-side comparison of Alnylam Pharmaceuticals, Inc. and IQVIA Holdings Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 5, 2026. Differences are shown without an overall score or investment verdict.

ALNY

Alnylam Pharmaceuticals, Inc.

$35.61B

$266.11HealthcareAt close: Sep 4, 2026, 4:00 PM ET

IQV

IQVIA Holdings Inc.

$44.07B

$267.77HealthcareAt close: Sep 4, 2026, 4:00 PM ET

Total return — ALNY vs IQV

growth of $100 · dividends reinvested · last 10y

ALNY +266.9% (+13.9%/yr)IQV +245.9% (+13.2%/yr)ALNY compounded faster over this window

ALNY IQV

ALNY vs IQV: by the numbers

•IQV is the larger company ($44.07B vs $35.61B market cap).
•IQV trades at the lower trailing earnings multiple (33.22 vs 44.95 P/E), one valuation lens rather than an overall verdict.
•ALNY converts more revenue to profit (16.82% vs 8.10% net margin).
•ALNY grew revenue faster over the past five years (47.53% vs 5.61% CAGR).

Metrics side by side

Valuation

Metric	ALNY	IQV
P/E ratio	44.95	33.22
Forward P/E	39.61	20.65
P/S ratio	7.66	2.66
P/B ratio	27.17	7.32
EV / EBITDA	34.48	17.05
FCF yield	1.47%	5.79%

Profitability

Metric	ALNY	IQV
Gross margin	79.72%	26.23%
Operating margin	20.81%	13.57%
Net margin	16.82%	8.10%
ROE	59.67%	22.28%
ROIC	24.71%	8.32%

Growth (annualized)

Metric	ALNY	IQV
Revenue CAGR (5Y)	47.53%	5.61%
EPS CAGR (5Y)	N/A	40.21%
FCF CAGR (5Y)	N/A	4.44%
Total return CAGR (5Y)	6.15%	0.34%

Frequently asked

Which has the lower trailing P/E, ALNY or IQV?: IQV has the lower trailing P/E: ALNY trades at 44.95 and IQV at 33.22. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, ALNY or IQV?: Over the past five years, ALNY grew revenue faster — ALNY at a 47.53% CAGR versus IQV at 5.61%.
Is ALNY or IQV more profitable?: ALNY runs the higher net margin — ALNY at 16.82% versus IQV at 8.10%.
How have ALNY and IQV total returns compared?: Over the past 10 years, ALNY delivered 14.42% and IQV delivered 13.27% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ALNY analysis Full IQV analysis Interactive comparison tool

Dig into the metrics

Alnylam Pharmaceuticals P/E ratio IQVIA P/E ratio Alnylam Pharmaceuticals ROE IQVIA ROE Alnylam Pharmaceuticals operating margin IQVIA operating margin Alnylam Pharmaceuticals revenue growth IQVIA revenue growth Alnylam Pharmaceuticals free cash flow IQVIA free cash flow

Alnylam Pharmaceuticals & IQVIA appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 5, 2026.